Lloyds TSB Group PLC
30 April 2003
The London Stock Exchange
RNS
Old Broad Street
London EC2N 1HP
30th April, 2003
Dear Sirs,
Lloyds TSB Group plc ordinary shares of 25p each
Notification of interests of directors
Hill Samuel ESOP Trustees Limited, as trustee of the Lloyds TSB Group Shareplan,
allocated 8,974,159 shares, held by Lloyds TSB Registrars Corporate Nominees
Limited AESOP2 account in its capacity as nominee, to participants in the
shareplan to satisfy allocations of "free shares" to staff under the shareplan
on 28 April 2003.
The following directors, together with some 80,000 other employees, are
potential participants in the shareplan and are, therefore, to be treated as
interested in the remaining 249,832 unallocated shares.
Mr. J.E. Daniels
Mr. P.B. Ellwood
Mr. M.E. Fairey
Mr. P.R. Hampton
Mr. A.G. Kane
Mr. D.P. Pritchard
Mr. M.D. Ross
Mr. S.C. Targett
This notification is made to comply with paragraph 16.13 of the listing rules.
Yours faithfully,
A.J. Michie
Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.